Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Silence Therapeutics

    NASDAQ: SLN · Real-Time Price · USD
    5.35
    -0.14 (-2.46%)
    At close: Aug 18, 2025, 1:11 PM
    -2.46%
    Bid 5.26
    Market Cap 252.7M
    Revenue (ttm) 26.21M
    Net Income (ttm) -56.93M
    EPS (ttm) -1.68
    PE Ratio (ttm) -3.18
    Forward PE -12.38
    Analyst Buy
    Ask 5.39
    Volume 28,061
    Avg. Volume (20D) 106,519
    Open 5.52
    Previous Close 5.49
    Day's Range 5.24 - 5.96
    52-Week Range 1.97 - 20.48
    Beta 1.39

    About SLN

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol SLN
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for SLN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    Silence Therapeutics is scheduled to release its earnings on Nov 13, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription
    6 months ago
    -15.45%
    Silence Therapeutics shares are trading lower afte... Unlock content with Pro Subscription
    news image

    1 week ago · businesswire.com

    Silence Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights

    LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), a global clinical-stage company developing novel siRNA (short interfering RNA) the...

    news image

    2 months ago · businesswire.com

    Silence Therapeutics Presents Additional Phase 1 Data Highlighting Promise of Divesiran as the Potential First-in-Class siRNA Treatment for Polycythemia Vera

    LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc (“Silence” or the “Company”) (Nasdaq: SLN), a global clinical-stage company developing novel siRNA (short interfering RNA) th...

    news image

    2 months ago · zacks.com

    Wall Street Analysts Think Silence Therapeutics (SLN) Could Surge 556.19%: Read This Before Placing a Bet

    The consensus price target hints at a 556.2% upside potential for Silence Therapeutics (SLN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earni...

    news image

    2 months ago · zacks.com

    Wall Street Analysts Believe Silence Therapeutics (SLN) Could Rally 590.66%: Here's is How to Trade

    The mean of analysts' price targets for Silence Therapeutics (SLN) points to a 590.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement a...

    Add to Watchlist